Outcomes of Cytoreductive Surgery for Well-Differentiated Metastatic Neuroendocrine Tumors in the Setting of Extra-Hepatic Metastases

#1352

Introduction: Cytoreduction with extra-hepatic disease for neuroendocrine tumors (NET) remains controversial

Aim(s): To define the outcomes of cytoreduction for metastatic NETs in the setting of extra-hepatic metastates.

Materials and methods: Patients undergoing cytoreductive surgery for G1 or G2 NETs with extra-hepatic metastases were identified from an institutional database (2003-2014). Primary outcomes were post-operative hormonal response, progression-free and overall survival (PFS, OS).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Hallet J

Authors: Hallet J, Koujanian S, Beyfuss K, Coburn N, Karanicolas P,

Keywords: cytoreduction, surgery,